Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001232108 | SCV001404654 | uncertain significance | Bardet-Biedl syndrome; McKusick-Kaufman syndrome | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 366 of the MKKS protein (p.Asn366Lys). This variant is present in population databases (rs147882975, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with MKKS-related conditions. ClinVar contains an entry for this variant (Variation ID: 958862). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MKKS protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
New York Genome Center | RCV002468200 | SCV002764452 | uncertain significance | McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6 | 2021-11-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002468200 | SCV002784936 | uncertain significance | McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6 | 2022-05-16 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004695239 | SCV005194876 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004538487 | SCV004719376 | uncertain significance | MKKS-related disorder | 2024-09-24 | no assertion criteria provided | clinical testing | The MKKS c.1098T>A variant is predicted to result in the amino acid substitution p.Asn366Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.076% of alleles in individuals of African descent in gnomAD, which may be too common to be an unreported primary cause of disease. Although we suspect this variant may possibly be benign, at this time its clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. |